Construction of an Oral Live Vector DNA Vaccine Encoding Antigen P32 Gene of Goatpox Virus

DING Jun-tao,WANG Ying,ZHANG Xue-bin,WU Jin-en,ZHENG Ya-dong,KONG He-lei,ZHANG Bei-bei
DOI: https://doi.org/10.16656/j.issn.1673-4696.2017.03.001
2017-01-01
Abstract:A novel oral live vector DNA vaccine encoding a P32 of goatpox virus without the transmembrane and hydrophobic domains,was constructed by using recombinant attenuated Salmonella typhimuriumX4550.Its safety,stability,immunogenicity and immune effects were detected and evaluated comprehensively by continuous cultivation in vitro,megadose inoculation test,immunohistochemical test,ELISA,etc.The results showed that X4550/pVAX1-P32 was of safety and stability in vitro and in vivo for BALB/c mice,and the survival rate reached to 100% after oral immunization with 1 × 1010 CFU X4550/pVAX1-P32.The X4550/pVAX1-P32 vaccine could be passaged stably above 100 generations and recombinant S.typhimurium was isolated from the spleen 10 days post-immunization.The attenuated S.typhimurium X4550 could delivery DNA to immunologic effector cells effectively and express bioactive P32 protein.Tawny particles were detected in the spleen cells from the immunized mice by immunohistochemistry test.The results of ELISA showed that X4550/pVAX1-P32 induced a longer persistent period(P<0.01) and higher antibody level than pVAX1-P32(0.01<P<0.05).These results indicate that the live vector DNA vaccine has good immunogenicity and can induce a lasting and high-level immune response,providing a basis for development of novel vaccines against goatpox.
What problem does this paper attempt to address?